Table 3.

Clinical outcomes of EUS - hepaticogastrostomy

Technical success rate, % (n/N)	98.3 (60/61)
EUS-HGS with FV	95.0 (58/61)
B2-EUS-HGS with FV	88.5 (54/61)
Overall clinical success rate, % (n/N)	88.3 (53/60)
Early (≤30 days) adverse event rate, % (n/N)	6.5 (4/61)
Early adverse events, grade
Fever	1, moderate
Peritonitis	1, moderate
Bile leakage	1, moderate
Internal stent migration	1, moderate
Bleeding	0
Transesophageal puncture	0
Late (>30 days) adverse event rate, % (n/N)	0.0 (0/61)

HGS: Hepaticogastrostomy; FV: Forward-viewing